← Back to Search

AleriTM sensors for Heart Failure

N/A
Waitlist Available
Led By Lior Jankelson
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour pre-surgery, during surgery and 3-5 hours post-surgery
Awards & highlights

Study Summary

This trialwill measure body parameters to test a sensor's effectiveness in monitoring hydration levels during an EP procedure.

Eligible Conditions
  • Arrhythmia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour pre-surgery, during surgery and 3-5 hours post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour pre-surgery, during surgery and 3-5 hours post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
changes in body water content before, during and after an Electrophysiology Procedure

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hydrostasis groupExperimental Treatment1 Intervention
50 study subjects scheduled for an EP procedure will have AleriTM sensors on subject's bicep, forearm, or wrist, to start data collection. Measurements will be made from the subject for a period of approximately 1 hours prior to the EP procedure. . Measurements will continue as patient is moved to the operating room. Once the EP procedure is complete, the subject will be transferred from the operating room to a hospital room, where they will stay overnight. Measurements will be made for 3-5hours post-operation.Detailed analysis will investigate how does AleriTM data correlate with known measures such as saline volume/rate, urine production volume, USG, Blood osmolality and body weight;
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AleriTM sensors
2022
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,702 Total Patients Enrolled
1 Trials studying Arrhythmia
135 Patients Enrolled for Arrhythmia
Lior JankelsonPrincipal InvestigatorNYU Langone Health

Media Library

Electrophysiology (EP) Procedure Clinical Trial Eligibility Overview. Trial Name: NCT04609683 — N/A
Arrhythmia Research Study Groups: Hydrostasis group
Arrhythmia Clinical Trial 2023: Electrophysiology (EP) Procedure Highlights & Side Effects. Trial Name: NCT04609683 — N/A
Electrophysiology (EP) Procedure 2023 Treatment Timeline for Medical Study. Trial Name: NCT04609683 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation include elderly individuals aged 85 and above?

"This medical research is open to individuals aged 18 or over, up until the age of 100."

Answered by AI

Do I qualify to partake in this medical exploration?

"60 individuals with arrhythmia between 18 and 100 years-old are needed to participate in the trial. Applicants must meet both criteria to be eligible for enrollment."

Answered by AI

Are there opportunities to join this research initiative at present?

"The trial, which was initially published on September 19th 2022 and last updated on January 6th 2023, is currently in the process of recruiting participants. This can be verified through clinicaltrials.gov."

Answered by AI

To what extent is enrollment being taken for this clinical experiment?

"Affirmative. According to the clinicaltrials.gov database, this trial is currently in search of volunteers. The initial listing was posted on September 19th 2022 and it has been revised most recently on January 6th 2023. This study requires 60 individuals from one medical centre to participate."

Answered by AI
~7 spots leftby Apr 2025